BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy

Author:

Zimmermann Tina,Thomas Leo,Baader-Pagler Tamara,Haebel Peter,Simon Eric,Reindl Wolfgang,Bajrami Besnik,Rist Wolfgang,Uphues Ingo,Drucker Daniel J.,Klein Holger,Santhanam Rakesh,Hamprecht Dieter,Neubauer Heike,Augustin Robert

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference95 articles.

1. Prevalence of obesity and severe obesity among adults: United States, 2017-2018;Hales;NCHS Data Brief,2020

2. Prevalence of obesity among adults, BMI ≥ 30, age-standardised estimates by WHO region,2017

3. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017;Collaboration;Lancet,2018

4. Nonalcoholic fatty liver disease: a systematic review;Rinella;JAMA,2015

5. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes;Godoy-Matos;Diabetology & Metabolic Syndrome,2020

Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3